Skip to main content

Advertisement

SpringerLink
Log in

Topiramate maculopathy

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

The purpose of this study is to present the first case of a pure ‘topiramate maculopathy’ without acute glaucoma and/or myopia, which form the classical syndrome. Design––Interventional/observational case report. Setting––Institutional University Teaching Hospital. Patient––A 22-year-old American female, after taking 100 mg of topiramate (Topamax®) a day for 6 days because of a migraine attack, complained of severe visual acuity deterioration of sudden onset in both eyes, regardless of distance (far or near), during the span of 1 day. A complete ocular examination was carried out. Best-corrected visual acuity (BCVA) in the right eye was hand motion and in the left eye was counting fingers. Cycloplegic refraction and pinhole did not improve the visual acuity of patient’s eyes. The anterior chamber depth was normal in both eyes. Tonometry was 14 mmHg in both eyes. Fundus biomicroscopy disclosed a maculopathy with macular striae and a cellophane-like reflex. Optical coherence tomography (OCT) showed an undulating profile with congruent retinal folds and choroidal layers plicae. Interventional/observation procedure––Immediate discontinuation of Topamax and steroid therapy. Main outcome measures––BCVA, cycloplegic refraction, tonometry, fundus photography, and OCT. Three days after suspension of Topomax and steroid therapy the patient’s BCVA was 6/6 in both eyes. Tonometry was 14 mmHg in both eyes. Fundus appearance and OCT features were nearly normal. After 2 years of follow-up, the patient’s BCVA, tonometry, macula, and OCT are stable in both eyes. In conclusion, an isolated (unassociated with glaucoma and/or induced myopia) acute maculopathy, previously known as being part of a rare syndrome, has been identified, described, and documented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Maryanoff BE, Nortey SO, Gardocki JF et al (1987) Anticonvulsant o-alkyl sulfamates. 2,3:4,5-Bis-o-(1-methylethylidene)-beta-d-fructopyranose sulfamate and related compounds. J Med Chem 30(5):880–887

    Article  PubMed  CAS  Google Scholar 

  2. Sen HA, O’Halloran HS, Lee WB (2001) Topiramate-induced acute myopia and retinal striae. Arch Ophthalmol 119(5):775–777

    PubMed  CAS  Google Scholar 

  3. Banta JT, Hoffman K, Budenz DL et al (2001) Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol 132(1):112–114

    Article  PubMed  CAS  Google Scholar 

  4. Ozturk BT, Genc E, Tokgoz M et al (2011) Ocular changes associated with topiramate. Curr Eye Res 36(1):47–52

    Article  PubMed  CAS  Google Scholar 

  5. Panday VA, Rhee DJ (2007) Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma. Compr Ophthalmol Update 8(5):271–276

    PubMed  Google Scholar 

  6. Fraunfelder FW, Fraunfelder PT, Keates EU (2004) Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology 111(1):109–111

    Article  PubMed  CAS  Google Scholar 

  7. Natesh S, Rajashekhara SK, Rao ASD et al (2010) Topiramate-induced angle closure with acute myopia, macular striae. Oman J Ophthalmol 3(1):26–28

    Article  PubMed  CAS  Google Scholar 

  8. Kumar M, Kesarwani S, Rao A et al (2012) Macular folds: an unusual association in topiramate toxicity. Clin Exp Optom. doi: 10.1111/j.1444-0938.2012.00722.x

  9. Asensio-Sanchez VM, Torreblanca-Aguera B, Martinez-Calvo S et al (2006) Severe ocular side effects with Topomax. Arch Soc Esp Ophthalmol 81:345–348

    CAS  Google Scholar 

  10. Tsui I, Casper D, Chou LC et al (2008) Electronegative electroretinogram associated with Topiramate toxicity and vitelliform maculopathy. Doc Ophthalmol 116:57–60

    Article  PubMed  Google Scholar 

  11. Beyenburg S, Weyland C, Reuber M (2009) Presumed topiramate-induced maculopathy. Epilepsy Behav p 556–9

  12. Shams P (2007) High frequency ultrasound biomicroscopy and anterior segment ocular coherence tomography in the management of acute angle closure. Alcon glaucoma Case Study Competition. Pinpoint Scotland, pp 10–13

  13. Lin RC, Cantrill HL, Mieler WF (2007) Retinal toxicities caused by systemic medications. Retinal physicians. http://www.retinalphysician.com/article.aspx?article= 101094. Accessed 20 May 2012

  14. Lachkar Y, Bouassida W (2007) Drug-induced acute angle closure glaucoma. Curr Opin Ophthalmol 18:129–133

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Vitreoretinal Unit, Department of Ophthalmology, Mater Dei University Hospital, Msida, MSD2090, Malta

    William Gualtieri

  2. Department of Ophthalmology, Mater Dei University Hospital, Msida, MSD2090, Malta

    Jan Janula

Authors
  1. William Gualtieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan Janula
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William Gualtieri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gualtieri, W., Janula, J. Topiramate maculopathy. Int Ophthalmol 33, 103–106 (2013). https://doi.org/10.1007/s10792-012-9640-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9640-3

Keywords

Search

Navigation